30-11-2021, 03:59 PM
It follows successful advanced trials in both the United States and Europe, reports Bloomberg. Study results are eliciting better immunity than AstraZeneca’s shot, with fewer side effects.
There is a growing belief that adding VLA2001 to the UK’s portfolio could significantly increase vaccination coverage and make an important contribution to the the fight against the latest developments in the COVID-19 pandemic.
https://dailybusinessgroup.co.uk/2021/11...t-omicron/
There is a growing belief that adding VLA2001 to the UK’s portfolio could significantly increase vaccination coverage and make an important contribution to the the fight against the latest developments in the COVID-19 pandemic.
https://dailybusinessgroup.co.uk/2021/11...t-omicron/